Toll Brothers (NYSE:TOL – Free Report) had its price target raised by Bank of America from $160.00 to $165.00 in a research note published on Thursday, Benzinga reports. Bank of America currently has a buy rating on the construction company’s stock. A number of other research firms have also recently commented on TOL. Wedbush lifted […]

Corning (NYSE:GLW – Free Report) had its price objective hoisted by Susquehanna from $46.00 to $55.00 in a report issued on Friday morning, Benzinga reports. Susquehanna currently has a positive rating on the electronics maker’s stock. GLW has been the topic of several other research reports. Oppenheimer restated an outperform rating and set a $47.00 […]

Laboratory Co. of America (NYSE:LH – Free Report) had its target price upped by Robert W. Baird from $278.00 to $282.00 in a report published on Friday, Benzinga reports. They currently have an outperform rating on the medical research company’s stock. Several other brokerages have also recently weighed in on LH. UBS Group upped their […]

Lennar (NYSE:LEN – Free Report) had its price target lifted by Bank of America from $171.00 to $190.00 in a research note issued to investors on Thursday, Benzinga reports. The firm currently has a neutral rating on the construction company’s stock. LEN has been the subject of several other reports. JPMorgan Chase & Co. cut […]

Thermo Fisher Scientific (NYSE:TMO – Free Report) had its target price increased by JPMorgan Chase & Co. from $650.00 to $670.00 in a research report released on Friday morning, Benzinga reports. The brokerage currently has an overweight rating on the medical research company’s stock. A number of other equities research analysts have also commented on […]

Endava (NYSE:DAVA – Free Report) had its target price decreased by Susquehanna from $66.00 to $55.00 in a research report released on Friday, Benzinga reports. Susquehanna currently has a positive rating on the stock. Several other equities analysts also recently weighed in on the company. TD Cowen dropped their price objective on Endava from $46.00 […]